Search / Trial NCT06225895

Bilateral Rhomboid Intercostal Block for Perioperative Analgesia in Patients Undergoing Bilateral Reduction Mammoplasty

Launched by ZAGAZIG UNIVERSITY · Jan 25, 2024

Trial Information

Current as of October 09, 2024

Recruiting

Keywords

Rhomboid Intercostal Block Erector Spinae Plane Block Reduction Mammoplasty Analgesia

Description

Reduction mammoplasty is the gold standard procedure for symptomatic breast hypertrophy and it is also used for contralateral breast symmetrisation following breast cancer surgery. Symptomatic hypermastia affects the quality of life of millions of women worldwide. The most frequent symptoms shown by more than two-thirds of patients are shoulder grooving, and back, shoulder, and neck pain. Reduction mammoplasty proved to be an effective treatment, both aesthetically and functionally, with a demonstrated consistently high patient satisfaction. Optimal pain management is an essential componen...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * Patient acceptance.
  • * Age 18-65 years old.
  • * BMI ≤ 35 kg/m2
  • * ASA I - II.
  • * Elective bilateral reduction mammoplasty surgery under general anesthesia.
  • * Duration of surgery within five hours
  • Exclusion Criteria:
  • * Patients on anti-platelet, anticoagulant, or B blocker drugs.
  • * Patients with acute decompensated heart failure, hypertension, heart block, coronary disease, Asthma
  • * History of allergy to the local anesthetics (LA) agents used in this study,
  • * Skin lesion at the needle insertion site,
  • * Those with bleeding disorders, sepsis, liver disease, psychiatric disorders, and pregnancy.

About Zagazig University

Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.

Locations

Zagazig, Alsharqia, Egypt

Zagazig, Alsharqia, Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0